Comparing permethrin and ivermectin for scabies in children
Treatments studied
Part of Infections, Skin clinical trials.
This study compares two common treatments for scabies—permethrin cream and ivermectin pills—to see which works better in children aged 6 to 15 years. If your child has scabies and is in this age range, they may be able to take part.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 6 and 15 years old.
- Your child has been diagnosed with scabies by a doctor.
- Your child has not had scabies before that needed treatment again.
- Your child is not allergic to either permethrin or ivermectin.
- Your child does not have widespread eczema or a skin infection called impetigo.
- Your child does not have liver or kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two different ways of using permethrin cream to treat scabies in babies and children up to 4 years old. It aims to find the safest and most effective treatment plan for this age group.
This trial tests two different strengths of permethrin cream to treat scabies. It may help if you have a confirmed case of scabies and are between 2 and 85 years old.
This study tests whether you can collect your own skin samples at home to help diagnose scabies. If you have or might have scabies, this study could offer an easier, less embarrassing way to check for it.
This trial tests if moxidectin works better than ivermectin for controlling river blindness and other neglected tropical diseases. Both drugs are given as a single dose during mass treatment campaigns in villages.
This study compares two treatments—itraconazole pills and ketoconazole shampoo—for moderate to severe dandruff on the scalp. It aims to find which works better for teens aged 14–17.
This trial tests whether crisaborole ointment works as well as tacrolimus ointment for children ages 2 to 18 with mild to moderate atopic dermatitis (eczema). If your child has eczema covering less than 30% of their body and hasn't used certain creams or medications recently, this study may be an option.
Hear when a new Scabies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.